Dr Parag Jasani

Consultant Haematologist @RFL and @UCLH, special interest in CLL and Lymphoma. Own views

[Dr Parag Jasani @drparagjasani]

@NitinJainMD @MDAndersonNews @DrHKantarjian @mkonople @GCC_Cortes @wwierda @mpdrc @Phari @myelomaMD @BldCancerDoc @doctorpemm Congratulations 👏 👏

[Dr Parag Jasani @drparagjasani]

@drshah73 @ak411cam @rcpsych @TrudiSene1 @NikkiLCochrane @SubodhDave @Asifmbachlani @RamkissonR1 @DrLadeSmith @DrAdrianJames @BapioTA @BAPIOUK Congratulations well deserved

[Dr Parag Jasani @drparagjasani]

@tobyeyre82 @BritSocHaem Congratulations Toby!

[Dr Parag Jasani @drparagjasani]

Met another CLL legend @NitinJainMD , great discussion on collaborations #ASH2022

[Dr Parag Jasani @drparagjasani]

It was great to see CLL legands @Othman_Al_Sawaf @aron_kater and @carsten_niemann at our poster today.

[Dr Parag Jasani @drparagjasani]

Come and visit our poster this evening. #ASH22

[Dr Parag Jasani @drparagjasani]

Great talk by @CwynKate on CNS prophylaxis #ASH2022

[Dr Parag Jasani @drparagjasani]

@SonaliKinra @NikkiKF @NicoleSAtkinson @parthaskar @HawthorneKamila Congrats Sonali 👏 👏

[Dr Parag Jasani @drparagjasani]

@graham74GC @tobyeyre82 @BritSocHaem Congratulations @tobyeyre82 👏👏

[Dr Parag Jasani @drparagjasani]

@tobyeyre82 @LRoekerMD @KargerPublisher Excellent to collaborate with @tobyeyre82 and @LRoekerMD

[Dr Parag Jasani @drparagjasani]

@SonaliKinra @BAPIOUK @RameshMehta15 @jsbamrah @DHariharanHPB Congarts Sonali

[NIHR Biomedical Research Centre: UCLH @UCLHresearch]

We're pleased to announce that researchers at the #NIHR @uclh Clinical Research Facility are the first in the world to trial a novel #cancer treatment - a significant milestone for them and their sponsors!

Learn more here: https://t.co/Azmg4exPKO #research

[Dr Parag Jasani @drparagjasani]

https://t.co/S4yDPzbNc6

[Sandy Douglas @DouglasVaccines]

This issue is, appropriately, contentious. As a vaccinologist - & citizen & relative of people in at-risk groups - I fully support the UK decision to increase dose intervals of both our Ox/AZ product and the Pfizer product. I'd happily receive either with a >8w gap. Here's why 🧵

[Dr Parag Jasani @drparagjasani]

@tobyeyre82 @michaelwangmd Agree, promising data, but small numbers. Need to wait for further data.

[Claire Roddie @drclaireroddie]

UCL comes in globally at #7 for novel CAR-T patents - quite an achievement @paulmaciocia @gcwkit @UCLTRO @uclcancer

[Leukaemia Care @LeukaemiaCareUK]

Our Richter Syndrome in Chronic Lymphocytic Leukaemia booklet looks at the development of this aggressive lymphoma in patients with CLL, and includes advice and support for those recently diagnosed > https://t.co/e3L4pPyKaz

[Toby Eyre @tobyeyre82]

Phase I trial
VLS-101 (ROR1 ADC) in R/R #mantle cell #lymphoma

All BTKi exposed
13/15 stopped due to PD

Neutropenia & PN main AEs
Impressive ORR 47% in MCL
Responses seem durable: 6/7 MCL pts response ongoing at 35, 38, 45, 47, 50 and 58 wk
Phase II planned
#MCL #ASH2020 #ROR1

[NEJM @NEJM]

Review Article: Chronic Lymphocytic Leukemia

[UK Chronic Lymphocytic Leukaemia (CLL) Forum @UkCllforum]

Updated UK #CLL forum guidance for the post lockdown period in the UK. #COVID19 #CLL